136 related articles for article (PubMed ID: 16012312)
1. Age dependence of diffusion-weighted magnetic resonance imaging findings in maple syrup urine disease encephalopathy.
Sakai M; Inoue Y; Oba H; Ishiguro A; Sekiguchi K; Tsukune Y; Mitomo M; Nakamura H
J Comput Assist Tomogr; 2005; 29(4):524-7. PubMed ID: 16012312
[TBL] [Abstract][Full Text] [Related]
2. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
Parmar H; Sitoh YY; Ho L
J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
[TBL] [Abstract][Full Text] [Related]
3. Maple syrup urine disease encephalopathy: a follow-up study in the acute stage using diffusion-weighted MRI.
Ha JS; Kim TK; Eun BL; Lee HS; Lee KY; Seol HY; Cha SH
Pediatr Radiol; 2004 Feb; 34(2):163-6. PubMed ID: 14504844
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the diffusion-weighted MRI in the diagnosis and follow-up of encephalopathy caused by maple syrup urine disease in a full-term newborn.
Ferraz-Filho JR; Floriano VH; Quirici MB; Albuquerque RP; Souza AS
Arq Neuropsiquiatr; 2009 Sep; 67(3A):719-23. PubMed ID: 19722062
[No Abstract] [Full Text] [Related]
6. Neonatal maple syrup urine disease case report and literature review.
Liu Q; Li F; Zhou J; Liu X; Peng J; Gong L
Medicine (Baltimore); 2022 Dec; 101(50):e32174. PubMed ID: 36550798
[TBL] [Abstract][Full Text] [Related]
7. Two novel compound heterozygous mutations in the BCKDHB gene that cause the intermittent form of maple syrup urine disease.
Guo Y; Liming L; Jiang L
Metab Brain Dis; 2015 Dec; 30(6):1395-400. PubMed ID: 26239723
[TBL] [Abstract][Full Text] [Related]
8. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
[TBL] [Abstract][Full Text] [Related]
9. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease.
Xia W; Yang W
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):805-8. PubMed ID: 25879313
[No Abstract] [Full Text] [Related]
11. Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.
Kilicarslan R; Alkan A; Demirkol D; Toprak H; Sharifov R
Jpn J Radiol; 2012 Jul; 30(6):522-5. PubMed ID: 22476847
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease.
Terek D; Koroglu O; Yalaz M; Gokben S; Calli C; Coker M; Kultursay N
Neuropediatrics; 2013 Aug; 44(4):208-12. PubMed ID: 23341096
[TBL] [Abstract][Full Text] [Related]
13. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.
Cheng A; Han L; Feng Y; Li H; Yao R; Wang D; Jin B
Diagn Interv Radiol; 2017; 23(5):398-402. PubMed ID: 28830848
[TBL] [Abstract][Full Text] [Related]
14. [Acute encephalopathy due to late-onset maple syrup urine disease in a school boy].
Qu SQ; Yang LC; Luan Z; Du K; Yang H
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):161-4. PubMed ID: 22433398
[TBL] [Abstract][Full Text] [Related]
15. Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis.
Couce ML; Ramos F; Bueno MA; Díaz J; Meavilla S; Bóveda MD; Fernández-Marmiesse A; García-Cazorla A
Eur J Paediatr Neurol; 2015 Nov; 19(6):652-9. PubMed ID: 26232051
[TBL] [Abstract][Full Text] [Related]
16. The electroencephalogram in neonatal maple syrup urine disease: a case report.
Agadi S; Sutton VR; Quach MM; Riviello JJ
Clin EEG Neurosci; 2012 Jan; 43(1):64-7. PubMed ID: 22423553
[TBL] [Abstract][Full Text] [Related]
17. [Maple Syrup Urine Disease in a newborn infant].
Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M
Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467
[TBL] [Abstract][Full Text] [Related]
18. Maple Syrup Urine Disease Complicated with Kyphoscoliosis and Myelopathy.
Hou JW
Pediatr Neonatol; 2016 Oct; 57(5):431-435. PubMed ID: 24486081
[TBL] [Abstract][Full Text] [Related]
19. [GENETIC AND METABOLIC URGENCIES IN THE NEONATAL INTENSIVE CARE UNIT: MAPLE SYRUP URINE DISEASE].
Páez Rojas PL; Suarez Obando F
Nutr Hosp; 2015 Jul; 32(1):420-5. PubMed ID: 26262748
[TBL] [Abstract][Full Text] [Related]
20. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.
Righini A; Ramenghi LA; Parini R; Triulzi F; Mosca F
J Neuroimaging; 2003 Apr; 13(2):162-5. PubMed ID: 12722501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
